Japanese medical device companies face shifting global market dynamics

The medical device sector is facing a period of transformation as global healthcare budgets tighten and growth in the Chinese market slows due to government-led centralized procurement policies. Analysts suggest that for companies to maintain profitability in an inflationary environment, they must focus on two key strategies: implementing effective price increases and pursuing strategic M&A to optimize their business portfolios.

In the Japanese market, companies like Shimadzu Corporation and Terumo Corporation are positioned as potential leaders in the coming five years. Conversely, Olympus Corporation may face headwinds as the era of its dominance in the endoscope market shifts. Future growth is expected to pivot away from China toward the United States and the Indo-Pacific region, particularly in emerging markets like India where hospital infrastructure is expanding.